Trends in caffeine use and association between clinical outcomes and timing of therapy in very low birth weight infants.

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Jornal de Pediatria

• Publication date

  2014-05-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.jpeds.2013.12.025PMID 24461786PMCID PMC3992195
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Early caffeine therapy and clinical outcomes in extremely preterm infants

  2013cited by this paper
• The relationship between patterns of intermittent hypoxia and retinopathy of prematurity in preterm infants

  2012cited by this paper
• Prevention of hyperoxia-mediated pulmonary inflammation in neonatal rats by caffeine

  2012cited by this paper
• Survival without Disability to Age 5 years After Neonatal Caffeine Therapy for Apnea of Prematurity

  2012cited by this paper
• Population based trends in mortality, morbidity and treatment for very preterm- and very low birth weight infants over 12 years

  2012cited by this paper
• Survival without disability to age 5 years after neonatal caffeine therapy for apnea of prematurity.

  2012cited by this paper
• Chronic or high dose acute caffeine treatment protects mice against oleic acid-induced acute lung injury via an adenosine A2A receptor-independent mechanism.

  2011cited by this paper
• A Tutorial and Case Study in Propensity Score Analysis: An Application to Estimating the Effect of In-Hospital Smoking Cessation Counseling on Mortality

  2011cited by this paper
• Prediction of bronchopulmonary dysplasia by postnatal age in extremely premature infants.

  2011cited by this paper
• The Pediatrix BabySteps Data Warehouse and the Pediatrix QualitySteps improvement project system--tools for "meaningful use" in continuous quality improvement.

  2010cited by this paper
• Early CPAP versus surfactant in extremely preterm infants.

  2010cited by this paper
• Methylxanthine treatment for apnoea in preterm infants.

  2010cited by this paper
• Does caffeine impair cerebral oxygenation and blood flow velocity in preterm infants?

  2010cited by this paper
• Patent Ductus Arteriosus of the Preterm Infant

  2010cited by this paper
• Caffeine for Apnea of Prematurity trial: benefits may vary in subgroups.

  2010cited by this paper
• Acute hemodynamic effects of caffeine administration in premature infants

  2009cited by this paper
• Evidence-Based Neonatal Drug Therapy for Prevention of Bronchopulmonary Dysplasia in Very-Low-Birth-Weight Infants

  2008cited by this paper
• Intensive care for extreme prematurity--moving beyond gestational age.

  2008cited by this paper
• Fluid regimens in the first week of life may increase risk of patent ductus arteriosus in extremely low birth weight infants

  2008cited by this paper
• Trends in neonatal morbidity and mortality for very low birthweight infants.

  2007cited by this paper
• Long-term effects of caffeine therapy for apnea of prematurity.

  2007cited by this paper
• Caffeine therapy for apnea of prematurity.

  2006cited by this paper
• Reported Medication Use in the Neonatal Intensive Care Unit: Data From a Large National Data Set

  2006cited by this paper
• Variable selection for propensity score models.

  2006cited by this paper
• Lung function in immature baboons with respiratory distress syndrome receiving early caffeine therapy: a pilot study.

  2005cited by this paper
• Cardiovascular effects of caffeine in men and women.

  2004cited by this paper
• Safety, Reliability, and Validity of a Physiologic Definition of Bronchopulmonary Dysplasia

  2003cited by this paper
• Pentoxifylline decreases tumor necrosis factor and interleukin-1 during high tidal volume.

  2003cited by this paper
• Organization of Ca2+ stores in vascular smooth muscle: functional implications.

  2002cited by this paper
• Caffeine impairs cerebral and intestinal blood flow velocity in preterm infants.

  2002cited by this paper
• Long-term effects of indomethacin prophylaxis in extremely-low-birth-weight infants.

  2001cited by this paper
• Effect of Caffeine on Oxygen Consumption and Metabolic Rate in Very Low Birth Weight Infants With Idiopathic Apnea

  2001cited by this paper
• Reducing Bias in a Propensity Score Matched-Pair Sample Using Greedy Matching Techniques

  2001cited by this paper
• Current Options in the Management of Apnea of Prematurity

  2000cited by this paper
• Renal effects of caffeine in preterm infants.

  1990cited by this paper
• Changes in pulmonary mechanics following caffeine administration in infants with bronchopulmonary dysplasia

  1989cited by this paper
• Arachidonic acid metabolism in cultured aortic endothelial cells. Effect of cAMP and 3-isobutyl-1-methylxanthine.

  1985cited by this paper
• The effects of caffeine and theophylline on diaphragm contractility.

  1984cited by this paper
• Effect of caffeine on control of breathing in infantile apnea.

  1983cited by this paper

• Early caffeine therapy decreases bronchopulmonary dysplasia but might increase mortality in preterm infants? a systematic review and meta-analysis

  2025cites this paper
• Caffeine Therapy in Preterm Neonates: Mechanisms, Clinical Applications, and Long-term Outcomes – A Narrative Review

  2025cites this paper
• Management of Apnoea in Extremely Preterm Infants: A European Survey

  2025cites this paper
• Caffeine Protects Newborn Rat Lungs Against the Effects of Hyperoxia and Intra‐Amniotic Enterotoxin

  2025cites this paper
• Neuroprotective effects of caffeine, erythropoietin, magnesium sulfate, and thyroxine in preterm infants: a network meta-analysis

  2025cites this paper
• Prophylactic Effect of Venous Caffeine on Apnea in the Very Preterm Infants

  2025cites this paper
• Methylxanthines: The Major Impact of Caffeine in Clinical Practice in Patients Diagnosed with Apnea of Prematurity

  2025cites this paper
• Caffeine-Associated Reduction in Patent Ductus Arteriosus (PDA) is Mediated in Part by Adenosine Receptor Antagonism.

  2025cites this paper
• Association of Early Caffeine Therapy with Risk Reduction of Moderate-to-Severe Bronchopulmonary Dysplasia in Preterm Infants

  2025cites this paper
• What is the Role of Caffeine in the Management of Preterm Infants?

  2025cites this paper
• Current and Emerging Therapies for Prevention and Treatment of Bronchopulmonary Dysplasia in Preterm Infants

  2025cites this paper
• Research progress on pathophysiologic mechanisms, clinical treatment and predictive biomarkers in bronchopulmonary dysplasia: from the perspective of oxidative stress

  2025cites this paper
• The Babyccino: The Role of Caffeine in the Prevention of Acute Kidney Injury in Neonates—A Literature Review

  2024cites this paper
• To Caffeinate or Not to Caffeinate? The Dilemma in Neonatal Apnea Management

  2024cites this paper
• Impact of early caffeine administration on respiratory outcomes in very preterm infants initially receiving invasive mechanical ventilation

  2024cites this paper
• Strategies for the prevention of bronchopulmonary dysplasia

  2024cites this paper
• Administration time of caffeine in preterm infants: systematic review and meta-analysis

  2024influential citation
• Is Early High-Dose Caffeine citrate Improves Outcomes in Preterm Infants?

  2024cites this paper
• Association of Caffeine Daily Dose With Respiratory Outcomes in Preterm Neonates: A Retrospective Cohort Study

  2024cites this paper
• Caffeine: how early is too early?

  2024cites this paper
• Prevalence, Prevention and Management of Bronchopulmonary Dysplasia

  2024cites this paper
• Effect of prophylactic caffeine in the treatment of apnea in very low birth weight infants: a meta-analysis

  2023cites this paper
• Effects of caffeine on diaphragmatic activity in preterm infants

  2023cites this paper
• Respiratory management in the premature neonate

  2023cites this paper
• Observational cohort study of use of caffeine in preterm infants and association between early caffeine use and neonatal outcomes

  2023cites this paper
• Effects of a small-baby protocol on early and long-term outcomes in extremely preterm infants: A quality improvement study.

  2023cites this paper
• Evaluation of a respiratory care protocol including less invasive surfactant administration in preterm infants

  2023cites this paper
• Early versus Late Caffeine Therapy Administration in Preterm Neonates: An Updated Systematic Review and Meta-Analysis

  2023cites this paper
• Caffeine and kidney function at two years in former extremely low gestational age neonates

  2023cites this paper
• A Modern Look at the Development of Intrauterine Pneumonia in Premature Newborns: Literature Review.

  2023cites this paper
• Therapeutic Interventions in Rat Models of Preterm Hypoxic Ischemic Injury: Effects of Hypothermia, Caffeine, and the Influence of Sex

  2022cites this paper
• Moving Bronchopulmonary Dysplasia Research from the Bedside to the Bench.

  2022cites this paper
• Caffeine and bronchopulmonary dysplasia: Clinical benefits and the mechanisms involved

  2022cites this paper
• Continuing interventions in a quality improvement bundle to reduce bronchopulmonary dysplasia

  2022cites this paper
• A survey of barriers and facilitators to caffeine use for apnoea of prematurity in low- and middle-income countries

  2022cites this paper
• National survey on caffeine use in neonatal units across the United Kingdom

  2022cites this paper
• Effects of early aminophylline therapy on clinical outcomes in premature infants.

  2022cites this paper
• Caffeine: Some of the Evidence behind Its Use and Abuse in the Preterm Infant

  2022cites this paper
• Bronchopulmonary Dysplasia

  2021cites this paper
• Caffeine: cardiorespiratory effects and tissue protection in animal models

  2021cites this paper
• RUNNIG HEAD: CAFFEINE: CARDIORESPIRATORY AND TISSUE EFFECTS. Caffeine: cardiorespiratory effects and tissue protection in animal models

  2021influential citation
• Evidence of an active Cushing reflex in a preterm neonate with hyaline membrane disease: a case report

  2021cites this paper
• Association between Caffeine Citrate and Incidence of Acute Kidney Injury in Preterms

  2021cites this paper
• The Center-Effect on Outcomes for Infants Born at Less than 25 Weeks.

  2021cites this paper
• Preventive Value Of Caffeine Citrate Against The Risk Of Acute Kidney Injury In Preterm Neonates

  2021cites this paper
• A Prediction Model of Extubation Failure Risk in Preterm Infants

  2021cites this paper
• Encephalopathy in Preterm Infants: Advances in Neuroprotection With Caffeine

  2021cites this paper
• Optimizing respiratory management in preterm infants: a review of adjuvant pharmacotherapies

  2021influential citation
• Early High-Dose Caffeine Improves Respiratory Outcomes in Preterm Infants

  2021cites this paper
• Diagnosis and treatment of neonatal cardiorespiratory events

  2021cites this paper
• Surfactant protein D and bronchopulmonary dysplasia: a new way to approach an old problem

  2021cites this paper
• Effects of Different Onset Times of Early Caffeine Treatment on Mesenteric Tissue Oxygenation and Necrotizing Enterocolitis: A Prospective, Randomized Study

  2021cites this paper
• Prophylactic versus therapeutic caffeine for apnea of prematurity: a randomized controlled trial

  2021cites this paper
• Potential Effects of Nutraceuticals in Retinopathy of Prematurity

  2021cites this paper
• Enteral Vitamin A for Reducing Severity of Bronchopulmonary Dysplasia: A Randomized Trial

  2021cites this paper
• Effects of Caffeine on Splanchnic Oxygenation in Preterm Infants

  2020cites this paper
• [Safety and efficacy of caffeine use started at different time in preterm infants: a multicenter study in Jiangsu Province, China].

  2020influential citation
• National and international guidelines for neonatal caffeine use: Are they evidenced-based?

  2020cites this paper
• Comentario sobre: Early Caffeine and Weaning from Mechanical Ventilation in Preterm Infants: A Randomized, Placebo-Controlled Trial Amaro C, Bello JA, Jain D, Ramnath A, D’Ugard C, Vanbuskirk S, et al The Journal of Pediatrics 2018; 196:52-7

  2020influential citation
• Control of Breathing

  2020cites this paper
• Use of caffeine for prevention of bronchopulmonary dysplasia

  2020cites this paper
• What is bronchopulmonary dysplasia and does caffeine prevent it?

  2020cites this paper
• When to start and stop caffeine and why respiratory status matters.

  2020cites this paper
• Confounding biases in studies on early- versus late-caffeine in preterm infants: a systematic review

  2020influential citation
• Bronchopulmonary Dysplasia: Then, Now, and Next

  2020cites this paper
• Can pentoxifylline and similar xanthine derivatives find a niche in COVID-19 therapeutic strategies? A ray of hope in the midst of the pandemic

  2020cites this paper
• Influence of prevention of caffeine citrate on cytokine profile and bronchopulmonary dysplasia in preterm infants with apnea.

  2020cites this paper
• [Comparison of the efficacy of domestic and imported caffeine citrate in the treatment of apnea in preterm infants: a prospective randomized double-blind controlled trial].

  2020influential citation
• Caffeine citrate maintenance doses effect on extubation and apnea postventilation in preterm infants

  2020cites this paper
• Effects of Single Loading Dose of Intravenous Caffeine on Cerebral Oxygenation in Preterm Infants

  2020cites this paper
• Pharmacological Therapies for the Prevention of Bronchopulmonary Dysplasia

  2020cites this paper
• Variations in preterm stabilisation practices and caffeine therapy between two European tertiary level neonatal units

  2020cites this paper
• Caffeine in preterm infants: where are we in 2020?

  2020cites this paper
• Caffeine not associated with irritable behaviour in very low-birth-weight infants.

  2019cites this paper
• Comparison of Caffeine versus Theophylline for apnea of prematurity

  2019cites this paper
• Is early caffeine therapy safe and effective for ventilated preterm infants?

  2019cites this paper
• Prevention of Bronchopulmonary Dysplasia: A Summary of Evidence-Based Strategies.

  2019cites this paper
• Respiratory frequency plasticity during development.

  2019cites this paper
• Dosing and Safety of Off-label Use of Caffeine Citrate in Premature Infants.

  2019cites this paper
• Stimulating and maintaining spontaneous breathing during transition of preterm infants

  2019cites this paper
• Apnea of Prematurity: An Update

  2019cites this paper
• Lung disease and pulmonary hypertension in the premature infant.

  2019cites this paper
• Anaesthetic concerns in preterm and term neonates

  2019cites this paper
• Caffeine Therapy in Preterm Infants: The Dose (and Timing) Make the Medicine

  2019cites this paper
• Bronchopulmonary dysplasia

  2019cites this paper
• Is earlier better when it comes giving caffeine to preterm infants or are we risking unnecessary treatment and serious harm?

  2019cites this paper
• Respiratory Control and Apnea in Premature Infants

  2019cites this paper
• Effect Of Early Caffeine Therapy On Weight Gain In Very Preterm Infants

  2019cites this paper
• Caffeine: an evidence-based success story in VLBW pharmacotherapy

  2018cites this paper
• Higher daily doses of caffeine lowered the incidence of moderate to severe neurodevelopmental disabilities in very low birth weight infants

  2018cites this paper
• Does duration of caffeine therapy in preterm infants born ≤1250 g at birth influence neurodevelopmental (ND) outcomes at 3 years of age?

  2018cites this paper
• Optimizing Caffeine Use and Risk of Bronchopulmonary Dysplasia in Preterm Infants: A Systematic Review, Meta-analysis, and Application of Grading of Recommendations Assessment, Development, and Evaluation Methodology.

  2018cites this paper
• Effects of caffeine on the preterm brain: An observational study.

  2018cites this paper
• Association Between Early Caffeine Citrate Administration and Risk of Acute Kidney Injury in Preterm Neonates: Results From the AWAKEN Study

  2018cites this paper
• Pulmonary Hypertension in Chronic Neonatal Lung Disease: Mechanisms and Targets

  2018cites this paper
• Preventing Continuous Positive Airway Pressure Failure: Evidence-Based and Physiologically Sound Practices from Delivery Room to the Neonatal Intensive Care Unit.

  2018cites this paper
• Comparison of Caffeine Versus Aminophylline for Apnea of Prematurity

  2018cites this paper
• [Clinical effect of early or late administration of caffeine citrate in prevention and treatment of apnea in very low birth weight infants].

  2018influential citation
• Bronchopulmonary dysplasia: clinical aspects and preventive and therapeutic strategies

  2018cites this paper
• Prematurity

  2018cites this paper